Terns Pharmaceuticals Income Statement (2020-2023) | TERN

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Operating items
Research & Development 7.24M7.61M5.40M7.77M8.73M5.96M7.15M9.46M8.14M8.66M12.16M10.66M
Selling, General & Administrative 2.18M2.49M3.33M1.00M4.56M4.86M4.71M5.42M5.69M5.42M5.13M6.17M
Operating Expenses 9.42M10.10M8.74M8.77M13.30M10.82M11.87M14.88M13.82M14.08M17.29M16.83M
Operating Income -9.42M-10.10M-8.74M-8.77M-13.30M-10.82M-11.87M-13.88M-13.82M-14.08M-17.29M-16.83M
EBIT -9.42M-10.10M-8.74M-8.77M-13.30M-10.82M-11.87M-13.88M-13.82M-14.08M-17.29M-16.83M-21.47M-17.82M-29.71M-21.02M
Non-operating items
Interest & Investment Income 0.05M0.00M0.00M0.00M0.01M0.06M0.05M0.06M0.07M0.21M0.50M1.33M
Other Non Operating Income 0.17M0.25M-0.39M10.67M-0.01M0.04M0.00M0.01M0.00M-0.05M-0.01M-0.00M
Non Operating Income 0.22M0.25M-2.75M-0.45M-0.01M0.09M0.05M0.07M0.07M0.16M0.48M1.32M
Net income details
EBT -9.21M-9.85M-11.49M-10.40M-13.30M-10.72M-11.81M-13.90M-13.75M-13.92M-16.81M-15.74M-21.47M-17.82M-29.71M-21.02M
Tax Provisions 0.10M0.71M0.04M0.01M0.02M0.43M0.02M0.01M0.01M0.32M0.06M0.07M0.06M0.07M
Profit After Tax -9.21M-9.85M-11.59M-9.93M-13.34M-10.74M-11.84M-14.25M-13.77M-13.93M-16.82M-15.82M-21.53M-17.90M-29.77M-21.02M
Income from Non-Controlling Interests -0.20M-0.16M-0.16M
Income from Continuing Operations -9.21M-9.85M-11.59M-11.11M-13.34M-10.74M-11.84M-14.33M-13.77M-13.93M-16.82M-16.06M-21.53M-17.90M-29.77M-21.08M
Consolidated Net Income -9.21M-9.85M-11.59M-11.11M-13.34M-10.74M-11.84M-14.33M-13.77M-13.93M-16.82M-16.06M-21.53M-17.90M-29.77M-21.08M
Income towards Parent Company -9.21M-9.85M-11.59M-11.11M-13.34M-10.74M-11.84M-14.33M-13.77M-13.93M-16.82M-16.06M-21.53M-17.90M-29.77M-21.08M
Net Income towards Common Stockholders -9.21M-9.85M-11.59M-11.11M-13.34M-10.74M-11.84M-14.33M-13.77M-13.93M-16.82M-16.06M-21.53M-17.90M-29.77M-21.08M
Additional items
EPS (Basic) -41.69-33.09-37.828.45-0.88-0.43-0.47-0.57-0.55-0.55-0.44-0.17-0.31-0.25-0.42-0.29
EPS (Weighted Average and Diluted) -0.47-0.63-0.55-0.55-0.44-0.17-0.31-0.25-0.42-0.29
Shares Outstanding (Weighted Average) 22.72M22.72M22.72M25.13M25.11M25.13M25.13M25.27M25.27M25.36M25.36M37.61M56.67M56.68M61.07M
Shares Outstanding (Diluted Average) 25.15M22.71M25.27M25.30M38.51M36.03M69.78M71.36M71.53M
EBITDA -9.38M-9.83M-11.23M-8.77M-13.45M-10.68M-11.83M-13.88M-14.33M-14.28M-16.93M-16.83M-21.12M-18.25M-29.83M-21.02M
Shares Outstanding 0.22M0.30M0.31M0.34M25.04M25.13M25.26M25.27M25.27M25.36M37.61M53.72M56.67M61.07M61.79M